Brad Haverkos, MD, discusses approaches for the management of mogamulizumab-associated rash in patients with cutaneous T-cell lymphoma.
Brad Haverkos, MD
Advertisement
Brad Haverkos, MD, is an associate professor of medicine-hematology in the School of Medicine at University of Colorado Anschutz.
Articles by Brad Haverkos, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
2
FDA Flashback: Breast Cancer Decisions and News From May 2026
3
ASCO 2026 Ushers In a New Era for Pancreatic Cancer, Expands Targeted Therapy Options Across the GI Spectrum
4
May’s GI Monthly Rewind: A Landmark Approval in CCA, Expanded Access for Daraxonrasib, and More Key Pipeline Updates
5